-
Sector Analysis
Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026
AxSpA is a chronic, immune-mediated inflammatory disease of the axial skeleton (sacroiliac joints and spine). It is characterized by a polyenthesitis, which at the molecular level leads to an osteitis and secondary synovitis. AxSpA is an umbrella term that includes ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-AxSpA). In some cases, nr-AxSpA is the earlier form of the disease and may progress to AS. This report provides an assessment of the pipeline, clinical, and commercial landscape of AxSpA. Overall, GlobalData...
-
Sector Analysis
Graft Versus Host Disease (GVHD): Competitive Landscape to 2026
Hematopoietic stem cell transplantation (HSCT) is the transplantation of autologous or allogeneic stem cells, and is used for the treatment of patients with hematologic disorders, which vary from malignant diseases to genetic anemias. Despite matching or minimally mismatching donors, there are minor histocompatibility antigens that might not match (or for other reasons), triggering the donor’s immune system to attack the recipient, causing the inflammatory disease unique to allogeneic HSCT known as graft versus host disease (GVHD). This report provides an...
-
Consumer Insights
KOL Perceptions of Ustekinumab Data Presented at ACR 2017
› This KOL Insight briefing focuses on perceptions of Ustekinumab Data Presented at ACR 2017
-
Sector Analysis
Peanut Allergy: Epidemiology Forecast to 2027
Peanut allergy is a type of food allergy in which the individual is allergic to peanut, which is part of the legume family. Peanut allergy is an immunoglobulin E (IgE) mediated type-I hypersensitivity reaction in which, once exposed to peanut, the body elicits an inappropriate immune response, causing the symptomology seen in allergic persons. The minimum dose of exposure to elicit an allergic response is highly variable, with some people only requiring trace amounts for a severe reaction. GlobalData epidemiologists...
-
Consumer Insights
KOL Perspectives: Update on Novel Candidates in Development for Lupus
› This KOL Insight briefing provides an update on novel candidates in development for Lupus
-
Product Insights
House Dust Mite Allergy Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “House Dust Mite Allergy Global Clinical Trials Review, H2, 2018" provides an overview of House Dust Mite Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Sarcoidosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H2, 2018" provides an overview of Sarcoidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcoidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2018" provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical trials on Sicca Syndrome (Sjogren). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027
Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune dysfunctions are key components that induce the development of psoriasis. The most common form of psoriasis is plaque psoriasis (psoriasis vulgaris), which is the focus of this report. Plaque psoriasis is defined using the 2018 International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnostic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.